NCT02408861 2026-01-21Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryNational Cancer Institute (NCI)Phase 1 Terminated79 enrolled 24 charts